Literature DB >> 453674

Xylazine-induced hyperglycemia in beef cattle.

R D Eichner, R L Prior, W G Kvasnicka.   

Abstract

Intravenous administration of xylazine to beef cattle (10 animals, 0.2 mg/kg of body weight) resulted in rapid onset (less than 15 minutes) of hyperglycemia. Plasma glucose values increased to 195 +/- 15 mg/dl and 305 +/- 10 mg/dl at 15 minutes and 3 hours, respectively. Concomitantly, plasma insulin concentrations dropped from 23 +/- 2 microU/ml before xylazine to 5.8 +/- 0.7 microU/ml and 2.4 +/- 0.3 microU/ml at 15 minutes and 3 hours, respectively. Parallel decreases (20%) were observed for percentage of hemoglobin, red blood cell number, and packed cell volume. Plasma urea nitrogen was significantly (P less than 0.01) incrased within 3 hours of xylazine administration (6.7 +/- 0.9 mg/dl vs 11.4 +/- 0.7 mg/dl). Marked changes in concentrations of plasma-free fatty acids were not observed. Alternative means of anesthesia must be considered in those instances in which biopsy material is to be used for studies of carbohydrate metabolism in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 453674

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Plasma glucose concentration is maintained during TSE infection of cattle and sheep.

Authors:  R A Horton; G G Allison; D Jayasena; P Rees Stevens; D Clifford; S Everest; R Jackman; J M Moorby
Journal:  Vet Res Commun       Date:  2007-09-06       Impact factor: 2.459

2.  Clinicophysiological effects of spinally administered ketamine and its combination with xylazine and medetomidine in healthy goats.

Authors:  P Kinjavdekar; G R Singh; H P Aithal; A M Pawde
Journal:  Vet Res Commun       Date:  2007-10       Impact factor: 2.459

3.  Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys.

Authors:  Yong-Fu Xiao; Bingdi Wang; Xiaoli Wang; Fenglai Du; Michael Benzinou; Yi-Xin Jim Wang
Journal:  BMC Anesthesiol       Date:  2013-10-20       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.